Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $372,232 - $562,593
10,884 New
10,884 $372,000
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $129,796 - $301,005
-4,674 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$54.9 - $105.21 $60,719 - $116,362
-1,106 Reduced 19.13%
4,674 $294,000
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $606,900 - $1.03 Million
5,780 New
5,780 $609,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.